Health news round-up: orforglipron, new gonorrhoea antibiotics and record high flu admissions A weekly summary of important developments in health news that you may have missed.…
Investigational weight-loss drug trial shows average reduced body weight of 30% According to results published by manufacturer Eli Lilly, participants taking 12mg of retatrutide lost an average of 28.7% of their body weight at 68 weeks, while patients taking placebo lost 2.1%.…
Switching between weight-loss medications This article proposes practical approaches for safe, effective switching between tirzepatide and semaglutide.…
Managing patients with cardiorenal metabolic disease An overview of the pathophysiology of cardiorenal metabolic disease, medication optimisation strategies and the role of the pharmacist in medication management and patient education.…
Mounjaro health benefits found to reverse one year after stopping drug Researchers said their findings “underscore the importance of continued obesity treatment”.…
Weight-loss drugs: is social media promotion to teenagers still a problem? Following an investigation conducted by The Pharmaceutical Journal in 2022, which revealed that weight-loss drugs were being promoted to teenagers on TikTok, we look at whether anything has changed.…
How safe are GLP-1s? As the use of weight-loss drugs continues to increase, there has been a rise in documented side effects. But what are the serious and unwanted effects of these drugs, and is Yellow Card reporting capturing enough information?…
MHRA raids illegal weight-loss jab production line worth more than £250,000 The Medicines and Healthcare products Regulatory Agency has told The Pharmaceutical Journal that the site of the raid is the first illicit production facility for weight-loss medicine discovered in the UK.…
Boots launches support service for patients coming off weight-loss drugs The service will provide users of the Boots Online Doctor weight-loss service unlimited support for 12 months, alongside various resources and ways to seek advice.…
Semaglutide benefits heart health regardless of weight lost Study authors found that the benefits of semaglutide were largely independent of how much weight patients lost in the first four months after taking the drug.…
